277 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
21
2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: Influence of the alkylcarboxamide substitution of position 4.
University of Lille
14
The design of 8-hydroxyquinoline tetracyclic lactams as HIV-1 integrase strand transfer inhibitors.
Glaxosmithkline
24
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends.
Shandong University
29
Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain.
Sapienza University of Rome
21
Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities.
University of Minnesota
12
Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors.
Beijing University of Technology
37
Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groups.
Glaxosmithkline
30
Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors.
Bristol Myers Squibb
3
A review on recent developments of indole-containing antiviral agents.
Central China Normal University
21
Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integrase.
Shandong University
17
Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV.
Boehringer Ingelheim (Canada)
25
4-amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high potency against raltegravir-resistant integrase mutants of HIV-1.
National Institutes of Health
29
Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75.
South China Normal University
29
Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors.
University of Lille
20
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.
Boehringer Ingelheim (Canada)
6
A new potential approach to block HIV-1 replication via protein-protein interaction and strand-transfer inhibition.
University of Messina
17
Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptase.
Sapienza University of Rome
78
Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
University of Southern California
47
CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
University of Tennessee Health Science Center
20
Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
Bristol Myers Squibb
22
Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors.
National Cancer Institute/Nih
25
Developing a dynamic pharmacophore model for HIV-1 integrase.
University of California
14
Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives.
Cnrs Umr 8532
23
Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
University of California
27
Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
Sapienza University of Rome
43
Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching.
National Cancer Institute-Bethesda
63
HIV-1 integrase pharmacophore: discovery of inhibitors through three-dimensional database searching.
National Cancer Institute-Bethesda
9
Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action.
National Cancer Institute-Bethesda
38
Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
National Cancer Institute-Bethesda
15
Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study.
National Cancer Institute-Bethesda
39
HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors.
University of Houston
2
Binding modes of two novel dinucleotide inhibitors of HIV-1 integrase.
The University of Iowa
12
Synthesis and HIV-1 integrase inhibitory activities of caffeoylglucosides.
Institute of Science and Technology
3
Recent report on indoles as a privileged anti-viral scaffold in drug discovery.
Guru Gobind Singh Indraprastha University
28
A mini-review on integrase inhibitors: The cornerstone of next-generation HIV treatment.
Mansoura University
35
Molecular design and evaluation of aza-polycyclic carbamoyl pyridones as HIV-1 integrase strand transfer inhibitors.
Shionogi
1
Viral Protein Dimerization Quality Control: A Design Strategy for a Potential Viral Inhibitor.
Shandong University
48
An Amazing 30-Year Journey around the DABO Family: A Medicinal Chemistry Lesson on a Versatile Class of Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors.
Sapienza University of Rome
4
Current status of the small molecule anti-HIV drugs in the pipeline or recently approved.
University of Rwanda
15
Quinolinonyl Derivatives as Dual Inhibitors of the HIV-1 Integrase Catalytic Site and Integrase-RNA interactions.
Sapienza University of Rome
15
Design and synthesis of novel and potent allosteric HIV-1 integrase inhibitors with a spirocyclic moiety.
Japan Tobacco
54
Inhibiting HCMV pUL89-C Endonuclease with Metal-Binding Compounds.
University of Minnesota
4
HIV-1 Integrase Inhibitor, Dihydroobionin B, and the Investigation of Its Extraordinary Specific Rotation.
Hirosaki University
14
Current medicinal chemistry strategies in the discovery of novel HIV-1 ribonuclease H inhibitors.
Shandong University
18
Ring substituent effects on biological activity of vinyl sulfones as inhibitors of HIV-1.
University of California
12
Advances in the development of HIV integrase strand transfer inhibitors.
Fudan University
5
Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome.
University of Southern California
54
Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.
Graduate School of The Chinese Academy of Sciences
4
From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes.
Università
2
Preventing Influenza A Virus Infection by Mixed Inhibition of Neuraminidase and Hemagglutinin by Divalent Inhibitors.
Utrecht University
8
Design, synthesis, and biological evaluation of novel tricyclic HIV-1 integrase inhibitors by modification of its pyridine ring.
Gilead Sciences
13
Design, synthesis, and SAR studies of novel and highly active tri-cyclic HIV integrase inhibitors.
Gilead Sciences
15
Effect of substitution on novel tricyclic HIV-1 integrase inhibitors.
Gilead Sciences
41
4,5-Dihydroxypyrimidine Methyl Carboxylates, Carboxylic Acids, and Carboxamides as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease.
University of Minnesota
12
A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors.
Merck Research Laboratories
4
Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.
Sapienza University of Rome
22
Dynamic pharmacophore model optimization: identification of novel HIV-1 integrase inhibitors.
University of Houston
8
Novel HIV-1 integrase inhibitors derived from quinolone antibiotics.
Central Pharmaceutical Research Institute
4
Beta-diketo acids with purine nucleobase scaffolds: novel, selective inhibitors of the strand transfer step of HIV integrase.
University of Georgia
4
HIV integrase inhibitors with nucleobase scaffolds: discovery of a highly potent anti-HIV agent.
University of Georgia
34
Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase.
University of Southern California
4
Intermolecular interactions in the crystal structures of potential HIV-1 integrase inhibitors.
Jagiellonian University
53
Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors
Shandong University
3
Synthesis and HIV-1 integrase inhibitory activities of caffeic acid dimers derived from Salvia officinalis.
Université
5
A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells.
Merck Research Laboratories
11
Synthesis and biological evaluation of geminal disulfones as HIV-1 integrase inhibitors.
University of California
4
Recent results from non-basic glycosidase inhibitors: How structural diversity can inform general strategies for improving inhibition potency.
University of Newcastle
2
Recent insight into the biological activities and SAR of quinolone derivatives as multifunctional scaffold.
Maharishi Markandeshwar (Deemed To Be University)
39
Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs.
University of Belgrade
25
Meroterpenoids produced by fungi: Occurrence, structural diversity, biological activities, and their molecular targets.
Guangzhou University of Chinese Medicine
42
Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
Tibotec
20
Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors.
University of Houston
12
Natural products from mangrove sediments-derived microbes: Structural diversity, bioactivities, biosynthesis, and total synthesis.
Chinese Academy of Sciences
43
Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase.
Sapienza University of Rome
10
Synthesis and HIV-1 integrase inhibitory activity of dimeric and tetrameric analogs of indolicidin.
National Cancer Institute-Frederick
11
HCV NS5b RNA-dependent RNA polymerase inhibitors: from alpha,gamma-diketoacids to 4,5-dihydroxypyrimidine- or 3-methyl-5-hydroxypyrimidinonecarboxylic acids. Design and synthesis.
Italy. Vinc
17
Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors.
Università
11
Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase.
Institute of Materia Medica
20
Linker-modified quinoline derivatives targeting HIV-1 integrase: synthesis and biological activity.
Cnrs Umr 8076
13
6-aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays.
Sapienza University of Rome
6
Design and synthesis of photoactivatable aryl diketo acid-containing HIV-1 integrase inhibitors as potential affinity probes.
Nci-Frederick
6
Catechol-substituted L-chicoric acid analogues as HIV integrase inhibitors.
Institute of Science & Technology
12
Azido-containing aryl beta-diketo acid HIV-1 integrase inhibitors.
National Cancer Institute-Bethesda
7
Interfacial peptide inhibitors of HIV-1 integrase activity and dimerization.
Purdue University
8
Four novel bis-(naphtho-gamma-pyrones) isolated from Fusarium species as inhibitors of HIV-1 integrase.
Merck Research Laboratories
7
Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells.
Merck Research Laboratories
2
Design, synthesis and SAR study of bridged tricyclic pyrimidinone carboxamides as HIV-1 integrase inhibitors.
Bristol Myers Squibb
14
Synthesis and HIV-1 integrase inhibitory activities of catechol and bis-catechol derivatives.
Université
8
DNA sequence-specific ligands. XVIII. Synthesis, physico-chemical properties; genetic, virological, and biochemical studies of fluorescent dimeric bisbenzimidazoles DBPA(n).
Russian Academy of Sciences
1
Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV-1 integrase.
The University of Iowa
42
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse Transcriptase.
Sapienza University of Rome
19
4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells.
Merck Research Laboratories
3
Heterocycle amide isosteres: An approach to overcoming resistance for HIV-1 integrase strand transfer inhibitors.
Bristol Myers Squibb
6
Design, synthesis and biological evaluation of imidazole and oxazole fragments as HIV-1 integrase-LEDGF/p75 disruptors and inhibitors of microbial pathogens.
University of The Witwatersrand
34
3-Hydroxypyrimidine-2,4-dione-5-N-benzylcarboxamides Potently Inhibit HIV-1 Integrase and RNase H.
University of Minnesota
5
Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.
Wuhan Institute of Technology
66
3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations.
University of Minnesota
22
Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture.
Université
18
Chemical and enzymatic modifications of integric acid and HIV-1 integrase inhibitory activity.
Merck Research Laboratories
17
Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors.
Bristol Myers Squibb
7
Synthetic routes and structure-activity relationships (SAR) of anti-HIV agents: A key review.
Wuhan University of Technology
24
Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linker.
University of Minnesota
6
Lamellarin alpha 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture.
Institute of Chemical Technology
22
Design, synthesis and biological evaluation of 3-hydroxyquinazoline-2,4(1H,3H)-diones as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and integrase.
Shandong University
27
Chicoric acid analogues as HIV-1 integrase inhibitors.
National Cancer Institute-Bethesda
3
Inhibition of HIV integrase by novel nucleotides bearing tricyclic bases.
University of Iowa
19
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.
University of Cagliari
5
Biological evaluation of molecules of the azaBINOL class as antiviral agents: Inhibition of HIV-1 RNase H activity by 7-isopropoxy-8-(naphth-1-yl)quinoline.
Oregon State University
45
Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
National Cancer Institute-Bethesda
20
Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells.
Paris-Sud University
14
An Isoquinoline Scaffold as a Novel Class of Allosteric HIV-1 Integrase Inhibitors.
The Ohio State University
18
Hydrazide-containing inhibitors of HIV-1 integrase.
National Cancer Institute-Bethesda
12
Discovery of HIV-1 integrase inhibitors by pharmacophore searching.
National Cancer Institute-Bethesda
1
(-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase.
Freie UniversitäT Berlin
20
Design, Synthesis, and Biological Evaluation of 1,2-Dihydroisoquinolines as HIV-1 Integrase Inhibitors.
University of Delhi
21
Synthesis of dihydropyrimidine α,γ-diketobutanoic acid derivatives targeting HIV integrase.
Univ. Orl£Ans Et Cnrs
9
Discovery of N-aryl-naphthylamines as in vitro inhibitors of the interaction between HIV integrase and the cofactor LEDGF/p75.
Sapienza University of Rome
4
Investigation on the sucrose binding pocket of HIV-1 Integrase by molecular dynamics and synergy experiments.
University of Siena
7
Optimization of rhodanine scaffold for the development of protein-protein interaction inhibitors.
University of Messina
10
Anti-HIV diarylpyrimidine-quinolone hybrids and their mode of action.
Fudan University
57
N-Substituted Quinolinonyl Diketo Acid Derivatives as HIV Integrase Strand Transfer Inhibitors and Their Activity against RNase H Function of Reverse Transcriptase.
Sapienza University of Rome
14
Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutants.
National Cancer Institute-Frederick
3
Inhibiting the HIV integration process: past, present, and the future.
Sapienza University of Rome
5
Specific features of HIV-1 integrase inhibition by bisphosphonate derivatives.
Lomonosov Moscow State University
4
Synthesis, anti-HIV activity, integrase enzyme inhibition and molecular modeling of catechol, hydroquinone and quinol labdane analogs.
Mumbai University
52
6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach.
Sapienza University of Rome
11
Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors.
University of Tennessee Health Science Center
21
Design and synthesis of novel pyrimidone analogues as HIV-1 integrase inhibitors.
Shandong University
16
Discovery of a novel 5-carbonyl-1H-imidazole-4-carboxamide class of inhibitors of the HIV-1 integrase-LEDGF/p75 interaction.
University of Southern California
19
4-Substituted 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as a Novel Class of HIV-1 Integrase Inhibitors.
University of Lille
3
Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).
Glaxosmithkline Research & Development
1
Notable difference in anti-HIV activity of integrase inhibitors as a consequence of geometric and enantiomeric configurations.
University of Georgia
15
Design of cell-permeable stapled peptides as HIV-1 integrase inhibitors.
Shanghai Institute of Materia Medica
16
Inhibition of HIV-1 integrase dimerization and activity with crosslinked interfacial peptides.
Purdue University
1
Dissecting the pharmacophore of curcumin. Which structural element is critical for which action?
University of Eastern Piedmont
6
Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.
Purdue University
41
Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction.
University of Southern California
38
Discovery of novel inhibitors of LEDGF/p75-IN protein-protein interactions.
University of Southern California
42
Naphthyridinone (NTD) integrase inhibitors: N1 protio and methyl combination substituent effects with C3 amide groups.
Glaxosmithkline Research & Development
32
Hydroxylated aromatic inhibitors of HIV-1 integrase.
National Cancer Institute-Bethesda
24
6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitors.
Frederick National Laboratory For Cancer Research
20
Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties.
Chinese Academy of Sciences
21
Discovery of inhibitors to block interactions of HIV-1 integrase with human LEDGF/p75 via structure-based virtual screening and bioassays.
East China University of Science and Technology
7
Carbamoyl pyridone HIV-1 integrase inhibitors. 1. Molecular design and establishment of an advanced two-metal binding pharmacophore.
Shionogi
2
Thiazoline peptides and a tris-phenethyl urea from Didemnum molle with anti-HIV activity.
University of Utah
20
Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity.
University of Lille
2
Discovery of small molecule HIV-1 integrase dimerization inhibitors.
University of Siena
28
Structure-Activity Relationship Studies of HIV-1 Integrase Oligonucleotide Inhibitors.
Lomonosov Moscow State University
15
Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors.
Beijing University of Technology
1
Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin α 20-sulfate analogues.
Nagasaki University
22
Combining symmetry elements results in potent naphthyridinone (NTD) HIV-1 integrase inhibitors.
Glaxosmithkline Research & Development
42
Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups.
Chinese Academy of Sciences
12
Ethyl malonate amides: a diketo acid offspring fragment for HIV integrase inhibition.
University of Silesia
35
Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
Jadavpur University
16
Development of tricyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitors.
National Cancer Institute-Frederick
29
Design and synthesis of novel N-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitors.
Pfizer
5
Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
Facult£S Universitaires Notre-Dame De La Paix (Fundp)
8
6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase.
University of Minnesota
3
In Vitro antiretroviral properties of S/GSK1349572, a next-generation HIV integrase inhibitor.
Shionogi
56
Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors.
University of Tennessee Health Science Center
15
Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors.
Katholieke Universiteit Leuven
7
Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.
National Institute of Pharmaceutical Education and Research
14
HIV-1 integrase strand-transfer inhibitors: design, synthesis and molecular modeling investigation.
University of Messina
15
2-hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4.
University of Lille
4
Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase.
Gilead Sciences
2
Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication.
University of Lyon 1
9
Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold.
Merck And
32
Development of the next generation of HIV-1 integrase inhibitors: pyrazolone as a novel inhibitor scaffold.
University of Southern California
4
The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.
Glaxosmithkline
15
Design of a series of bicyclic HIV-1 integrase inhibitors. Part 2: azoles: effective metal chelators.
Avexa
32
Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: selection of the scaffold.
Avexa
26
Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.
Tokyo Medical and Dental University
3
Tricyclononene carboxamide derivatives as novel anti-HIV-1 agents.
Beijing Institute of Biotechnology
12
Synthesis of polyhydroxylated aromatics having amidation of piperazine nitrogen as HIV-1 integrase inhibitor.
Beijing University of Technology
13
Antiviral agents 2. Synthesis of trimeric naphthoquinone analogues of conocurvone and their antiviral evaluation against HIV.
Monash University (Parkville Campus)
15
Development of 2-pyrrolidinyl-N-methyl pyrimidones as potent and orally bioavailable HIV integrase inhibitors.
Irbm-Mrl
29
New chloro,fluorobenzylindole derivatives as integrase strand-transfer inhibitors (INSTIs) and their mode of action.
University of Messina
48
CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
Lanzhou University
15
New 2-arylnaphthalenediols and triol inhibitors of HIV-1 integrase--discovery of a new polyhydroxylated antiviral agent.
Lille University of Science and Technology
5
Peptide HIV-1 integrase inhibitors from HIV-1 gene products.
Tokyo Medical and Dental University
28
Synthesis and anti-HIV-1 integrase activity of modified dinucleotides.
University of Orleans
5
Inhibition of the dimerization and active site of HIV-1 protease by secondary metabolites from the Vietnamese mushroom Ganoderma colossum.
University of Toyama
33
Multivariate QSAR study of 4,5-dihydroxypyrimidine carboxamides as HIV-1 integrase inhibitors.
Universidade Estadual Do Oeste Do Paran£
4
Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.
The Hebrew University of Jerusalem
24
Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality.
National Cancer Institute-Frederick
45
Analysis of binding parameters of HIV-1 integrase inhibitors: correlates of drug inhibition and resistance.
University of Cyprus
27
Dihydroxy-pyrimidine and N-methylpyrimidone HIV-integrase inhibitors: improving cell based activity by the quaternarization of a chiral center.
Irbm-Merck Research Laboratories Rome
3
Structural and theoretical studies of [6-bromo-1-(4-fluorophenylmethyl)-4(1H)-quinolinon-3-yl)]-4-hydroxy-2-oxo-3-butenoïc acid as HIV-1 integrase inhibitor.
Facult£S Universitaires Notre-Dame De La Paix
22
Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester.
Shandong University
49
N-(4-Fluorobenzyl)-3-hydroxy-9,9-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a]pyrimidine-2-carboxamides a novel class of potent HIV-1 integrase inhibitors.
Irbm-Mrl
55
Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones.
National Cancer Institute-Frederick
28
Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H.
National Cancer Institute
52
Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors.
Jt
7
Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program.
National Cancer Institute
22
Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
University of Siena
27
Synthesis and anti-HIV-1 integrase activities of 3-aroyl-2,3-dihydro-1,1-dioxo-1,4,2-benzodithiazines.
Medical University of Gda?Sk
17
Amide-containing diketoacids as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity.
Shandong University
24
3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates--a new class of HIV-1 integrase inhibitors.
Merck Research Laboratories Rome
11
Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors.
University of Sassari
40
Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines.
Zhejiang University
23
Docking studies on a new human immunodeficiency virus integrase-Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions.
Universita Di Messina
21
Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.
University of Lille
22
Discovery of 3-acetyl-4-hydroxy-2-pyranone derivatives and their difluoridoborate complexes as a novel class of HIV-1 integrase inhibitors.
University of Southern California
8
Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase.
Merck Research Laboratories
8
Brominated polyacetylenes from the Philippines sponge Diplastrella sp.
University of California At San Diego
2
Isolation, structure, and HIV-1 integrase inhibitory activity of Cytosporic acid, a fungal metabolite produced by a Cytospora sp.
Merck Research Laboratories
1
Synthesis and structure-activity relationship study of lamellarin derivatives.
Nagasaki University
27
Synthesis, anti-HIV-1 integrase, and cytotoxic activities of 4-chloro-N-(4-oxopyrimidin-2-yl)-2-mercaptobenzenesulfonamide derivatives.
Medical University of Gdansk
14
Synthesis and biological activities of a series of 4,5-diaryl-3-hydroxy-2(5H)-furanones.
University of Lille
5
Synthesis and antiviral properties of some polyphenols related to Salvia genus.
Umr Cnrs 8009
23
Investigations on the 4-quinolone-3-carboxylic acid motif. 1. Synthesis and structure-activity relationship of a class of human immunodeficiency virus type 1 integrase inhibitors.
Universita Degli Studi Di Siena
9
Efficient synthesis and utilization of phenyl-substituted heteroaromatic carboxylic acids as aryl diketo acid isosteres in the design of novel HIV-1 integrase inhibitors.
Chinese Academy of Sciences
26
Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities.
Fondazione Cenci Bolognettiuniversit£
34
Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation.
Chinese Academy of Sciences
1
Dolastatin 3 and two novel cyclic peptides from a palauan collection of Lyngbya majuscula.
University of California At San Diego
10
A new flavonol glycoside gallate ester from Acer okamotoanum and its inhibitory activity against human immunodeficiency virus-1 (HIV-1) integrase.
Korea Institute of Science & Technology
13
Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus.
Korea Institute of Science and Technology
5
Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides.
The Hebrew University of Jerusalem
9
The complestatins as HIV-1 integrase inhibitors. Efficient isolation, structure elucidation, and inhibitory activities of isocomplestatin, chloropeptin I, new complestatins, A and B, and acid-hydrolysis products of chloropeptin I.
Merck Research Laboratories
1
Isolation, structure, absolute stereochemistry, and HIV-1 integrase inhibitory activity of integrasone, a novel fungal polyketide.
Merck Research Laboratories
13
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series.
University of Messina
20
Development of 2-t butyl-N-methyl pyrimidones as potent inhibitors of HIV integrase.
Irbm-Mrl Rome
4
Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.
University of Lille
3
Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium.
Hebrew University of Jerusalem
25
Quinolone 3-carboxylic acid pharmacophore: design of second generation HIV-1 integrase inhibitors.
University of Southern California
43
2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-one-based HIV-1 integrase inhibitors.
National Cancer Institute-Frederick
3
Calculation of binding energy using BLYP/MM for the HIV-1 integrase complexed with the S-1360 and two analogues.
Universidade Federal Do Par£
12
Development of integrase inhibitors for treatment of AIDS: an overview.
K.L.E.S. College of Pharmacy
17
Discovery of novel non-cytotoxic salicylhydrazide containing HIV-1 integrase inhibitors.
University of Southern California
81
Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore.
University of Southern California
9
Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.
Birla Institute of Technology and Science
9
Synthesis and HIV-1 integrase inhibitory activity of spiroundecane(ene) derivatives.
Siberian Branch of The Russian Academy of Sciences
16
8-Hydroxy-3,4-dihydropyrrolo[1,2-a]pyrazine-1(2H)-one HIV-1 integrase inhibitors.
Merck Research Laboratories
18
Substituted 2-pyrrolinone inhibitors of HIV-1 integrase.
University of Southern California
11
Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors.
Merck Research Laboratories
9
Virtual screening application of a model of full-length HIV-1 integrase complexed with viral DNA.
National Cancer Institute
30
Toward novel HIV-1 integrase binding inhibitors: molecular modeling, synthesis, and biological studies.
University of Siena
11
Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of L-chicoric acid, as new HIV-1 integrase inhibitors.
Korea Institute of Science & Technology
31
From dihydroxypyrimidine carboxylic acids to carboxamide HIV-1 integrase inhibitors: SAR around the amide moiety.
Irbm-Mrl Rome
40
Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors.
University of Tennessee Health Science Center
49
6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H.
University of Minnesota
49
6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity.
University of Minnesota
27
Synthesis and Evaluation of Aryl Quinolines as HIV-1 Integrase Multimerization Inhibitors.
University of Southern Mississippi
1
DNA sequence-specific ligands. XVII. Synthesis, spectral properties, virological and biochemical studies of fluorescent dimeric bisbenzimidazoles DBA(n).
Engelhardt Institute of Molecular Biology Russian Academy of Sciences
9
Synthesis and evaluation of substituted 4-arylimino-3-hydroxybutanoic acids as potential HIV-1 integrase inhibitors.
Rhodes University
5
Design, synthesis and biological evaluation of (E)-3,4-dihydroxystyryl 4-acylaminophenethyl sulfone, sulfoxide derivatives as dual inhibitors of HIV-1 CCR5 and integrase.
Peking University
13
5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.
Shandong University
21
Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H.
University of Minnesota
16
The discovery and preclinical evaluation of BMS-707035, a potent HIV-1 integrase strand transfer inhibitor.
Bristol Myers Squibb
